ASO Landmark Series

Emory users, open this instance of PubMed, then click the links below for full-text article access.

McMasters KM. Introducing: The Landmark Series. Ann Surg Oncol. 2020 Jan;27(1):1-2.

The Annals of Surgical Oncology, the journal of the Society of Surgical Oncology, has created The Landmark Article Series.

“The Landmark Series is designed to trace the origins of current multidisciplinary therapy for each type of solid tumor, and demonstrate the logical progression of clinical trials and other key evidence. It is meant to be an educational resource, for trainees and practicing cancer specialists alike, in the understanding of evidence-based cancer management. Practice-changing clinical trials and other key evidence that inform our current treatment guidelines will be summarized and reviewed. Expert authors will provide context and commentary to enhance the value to the reader.” (McMasters, p.1).


Beasley GM, et al. The Landmark Series: Regional Therapy of Recurrent Cutaneous Melanoma. Ann Surg Oncol. 2020 Jan;27(1):35-42.

Egger ME, et al. The Sunbelt Melanoma Trial. Ann Surg Oncol. 2020 Jan;27(1):28-34.

Bello DM, Faries MB. The Landmark Series: MSLT-1, MSLT-2 and DeCOG
(Management of Lymph Nodes)
. Ann Surg Oncol. 2020 Jan;27(1):15-21.

Lee AY, Berman RS. The Landmark Series: Non-melanoma Skin Cancers. Ann Surg
Oncol. 2020 Jan;27(1):22-27.

Angeles CV, Wong SL, Karakousis G. The Landmark Series: Randomized Trials
Examining Surgical Margins for Cutaneous Melanoma
. Ann Surg Oncol. 2020 Jan;27(1):3-12.

Fisher CS, et al. The Landmark Series: Axillary Management in Breast Cancer. Ann Surg Oncol. 2020 Mar;27(3):724-729.

Valente SA, Shah C. The Landmark Series: Adjuvant Radiation Therapy for Breast Cancer. Ann Surg Oncol. 2020 Jul;27(7):2203-2211.

Eby ME, Seder CW. The Landmark Series: Multimodality Therapy for Stage 3A
Non-small Cell Lung Cancer
. Ann Surg Oncol. 2020 Aug;27(8):3030-3036.

Spillane AJ, Menzies AM, van Akkooi ACJ. The Landmark Series: Neoadjuvant
Systemic Therapy (NAST) for Stage 3 Melanoma Patients – A Potential Paradigm
Shift in Management
. Ann Surg Oncol. 2020 Jul;27(7):2188-2200.

Cloyd JM, Ejaz A, Pawlik TM. The Landmark Series: Intrahepatic
Cholangiocarcinoma
. Ann Surg Oncol. 2020 Aug;27(8):2859-2865.

Gamboa AC, Maithel SK. The Landmark Series: Gallbladder Cancer. Ann Surg Oncol. 2020 Aug;27(8):2846-2858.

Peacock O, Chang GJ. The Landmark Series: Management of Lateral Lymph Nodes in Locally Advanced Rectal Cancer. Ann Surg Oncol. 2020 Aug;27(8):2723-2731.

Weiss A, King TA, Mittendorf EA. The Landmark Series: Neoadjuvant Endocrine
Therapy for Breast Cancer
. Ann Surg Oncol. 2020 Sep;27(9):3393-3401.

Gangi A, Howe JR. The Landmark Series: Neuroendocrine Tumor Liver Metastases. Ann Surg Oncol. 2020 Sep;27(9):3270-3280.

Allaix ME, Rebecchi F, Fichera A. The Landmark Series: Minimally Invasive
(Laparoscopic and Robotic) Colorectal Cancer Surgery
. Ann Surg Oncol. 2020 Oct;27(10): 3704-3715.

Roland CL, van Houdt W, Gronchi A. The Landmark Series: Multimodality Treatment of Extremity Sarcoma. Ann Surg Oncol. 2020 Oct;27(10):3672-3682.

Keung EZ, Raut CP, Rutkowski P. The Landmark Series: Systemic Therapy for Resectable Gastrointestinal Stromal Tumors. Ann Surg Oncol. 2020 Oct;27(10):3659-3671.

Kawaguchi Y, Vauthey JN. The Landmark Series: Randomized Control Trials Examining Perioperative Chemotherapy and Postoperative Adjuvant Chemotherapy for Resectable Colorectal Liver Metastasis. Ann Surg Oncol. 2020 Oct;27(11):4263-4270.

Elmore LC, Dietz JR, Myckatyn TM, Margenthaler JA. The Landmark Series: Mastectomy Trials (Skin-Sparing and Nipple-Sparing and Reconstruction Landmark Trials). Ann Surg Oncol. 2021 Jan;28(1):273-280.

Cloyd JM, Poultsides GA. The Landmark Series: Pancreatic Neuroendocrine
Tumors
. Ann Surg Oncol. 2021 Feb;28(2):1039-1049.

Van Buren G 2nd, Vollmer CM Jr. The Landmark Series: Mitigation of the
Postoperative Pancreatic Fistula
. Ann Surg Oncol. 2021 Feb;28(2):1052-1059.

Basaran D, Leitao MM Jr. The Landmark Series: Minimally Invasive Surgery for
Cervical Cancer
. Ann Surg Oncol. 2021 Jan;28(1):204-211.

Alonso S, Saltz L. The Landmark Series: Chemotherapy for Non-Metastatic Colon Cancer. Ann Surg Oncol. 2021 Feb;28(2):995-1001.

van Hilst J, et al. The Landmark Series: Minimally Invasive Pancreatic Resection. Ann Surg Oncol. 2021 Mar;28(3):1447-1456.

Rocha FG. Landmark Series: Immunotherapy and Targeted Therapy for Pancreatic
Cancer
. Ann Surg Oncol. 2021 Mar;28(3):1400-1406.

Fiore M, et al. The Landmark Series: Desmoid. Ann Surg Oncol. 2021 Mar;28(3): 1682-1689.

Dillhoff M, Pawlik TM. Role of Node Dissection in Pancreatic Tumor Resection. Ann Surg Oncol. 2021 Apr;28(4):2374-2381.

He J, Schulick RD, Del Chiaro M. Landmark Series: Neoadjuvant Treatment in
Borderline Resectable Pancreatic Cancer
. Ann Surg Oncol. 2021 Mar;28(3):1514-1520.

Tran CG, Sherman SK, Howe JR. The Landmark Series: Management of Small Bowel
Neuroendocrine Tumors
. Ann Surg Oncol. 2021 May;28(5):2741-2751.

Leon-Ferre RA, Hieken TJ, Boughey JC. The Landmark Series: Neoadjuvant
Chemotherapy for Triple-Negative and HER2-Positive Breast Cancer
. Ann Surg Oncol. 2021 Apr;28(4):2111-2119.

Margenthaler JA, Dietz JR, Chatterjee A. The Landmark Series: Breast Conservation Trials (including oncoplastic breast surgery). Ann Surg Oncol. 2021 Apr;28(4):2120-2127.

Kantor T, Wakeam E. Landmark Trials in the Surgical Management of Mesothelioma. Ann Surg Oncol. 2021 Apr;28(4):2037-2047.

Sachs TE, Tseng JF. Landmark Series in Pancreatic Tumors: Anastomotic Techniques and Route of Reconstruction. Ann Surg Oncol. 2021 Apr;28(4):2227-2234.

White RR, Murphy JD, Martin RCG. The Landmark Series: Locally Advanced Pancreatic Cancer and Ablative Therapy Options. Ann Surg Oncol. 2021 Aug;28(8):4173-4180.

Demarest CT, Chang AC. The Landmark Series: Multimodal Therapy for Esophageal Cancer. Ann Surg Oncol. 2021 Jun;28(6):3375-3382.

Ng SP, Leong T. Role of Radiation Therapy in Gastric Cancer. Ann Surg Oncol. 2021 Aug;28(8):4151-4157.

Soares KC, Jarnagin WR. The Landmark Series: Hilar Cholangiocarcinoma. Ann Surg Oncol. 2021 Aug;28(8):4158-4170.

Dineen SP, Pimiento JM. The Landmark Series: Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) for Treatment of Gastric Cancer Metastatic to Peritoneum. Ann Surg Oncol. 2021 Aug;28(8):4130-4137.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s